Avoid any provider that skips a health review or offers unusually low prices without explaining what is included
Patients who complete genetic testing often refine their dose escalation strategy by week 2-3, preventing unnecessary delays in reaching their therapeutic window
Figure 1 Figure 2 Figure 3 Figure 4 Discussion Although MC is known as a very rare condition, recent study reported a rate of 1.8% MC among approximately 350,000 cases ( Most scholars believe that MC is a benign and reversible noninflammatory intestinal mucosal lesion ( In our case, it is still unclear as to whether colon cancer is correlated with MC, or developed simply by coincidence
To enhance the protection of the mucus barrier, different strategies have been developed, including physical reinforcement, pathogen neutralization, muco-trapping, mucus rehydration and MCC enhancement (Fig
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: a new RNAi therapeutic in infants and young children